共 50 条
- [21] Minimal residual disease clinical monitoring and depth of response in multiple myeloma.JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)Martinez-Lopez, JoaquinWong, Sandy Wai KuanShah, NinaBahri, NatashaZhou, KailiMartin, Thomas G.Wolf, Jeffrey Lee
- [22] IMMUNOPHENOTYPIC INSTABILITY IN MULTIPLE MYELOMA. IMPLICATIONS FOR MINIMAL RESIDUAL DISEASE DETECTIONCYTOMETRY PART B-CLINICAL CYTOMETRY, 2010, 78B (06) : 451 - 451Colado, EnriqueAlonso-Nogues, EvaFanjul, EmiliaRamirez, AngelRayon, Consolacion
- [24] Controversies in the Assessment of Minimal Residual Disease in Multiple Myeloma: Clinical Significance of Minimal Residual Disease Negativity Using Highly Sensitive TechniquesCurrent Hematologic Malignancy Reports, 2014, 9 : 368 - 378Noa BiranScott ElyAjai Chari
- [25] Genomic Landscape Predictive of Minimal Residual Disease (MRD) in Multiple Myeloma (MM)BLOOD, 2015, 126 (23)Samur, Mehmet K.Minvielle, StephaneMagrangeas, FlorenceParmigiani, GiovanniAnderson, Kenneth C.Moreau, PhilippeAttal, MichelAvet-Loiseau, HerveMunshi, Nikhil C.
- [26] Minimal residual disease negativity using deep sequencing is a major prognostic factor in multiple myelomaBLOOD, 2018, 132 (23) : 2456 - 2464Perrot, AuroreLauwers-Cances, ValerieCorre, JillRobillard, NellyHulin, CyrilleChretien, Marie-LorraineDejoie, ThomasMaheo, SabrinaStoppa, Anne-MariePegourie, BrigitteKarlin, LionelGarderet, LaurentArnulf, BertrandDoyen, ChantalMeuleman, NathalieRoyer, BrunoEveillard, Jean-RichardBenboubker, LotfiDib, MamounDecaux, OlivierJaccard, ArnaudBelhadj, KarimBrechignac, SabineKolb, BrigitteFohrer, CecileMohty, MohamadMacro, MargaretRichardson, Paul G.Carlton, VictoriaMoorhead, MartinWillis, TomFaham, MalekAnderson, Kenneth C.Harousseau, Jean-LucLeleu, XavierFacon, ThierryMoreau, PhilippeAttal, MichelAvet-Loiseau, HerveMunshi, Nikhil
- [27] Long-Term Sustained Minimal Residual Disease (MRD) Negativity in Multiple Myeloma Patients Treated with Lenalidomide Maintenance Therapy: A Clinical and Correlative Phase 2 StudyBLOOD, 2019, 134Landgren, OlaMastey, DonnaLesokhin, Alexander M.Smith, Eric L.Shah, Urvi A.Mailankody, ShamHultcrantz, MalinHassoun, HaniLu, Sydney X.Salcedo, MeghanDiab, VictoriaWerner, KellyRispoli, JennaSams, AllisonVerducci, DennisJones, KatieSchlossman, JuliaChansakul, AisaraHarrison, AngelaCiardiello, AmandaTavitian, ElizabethShekarkhand, TalaRustad, EvenYellapantula, VenkataMaura, FrancescoPeterson, Tim J.Devlin, Sean M.Landau, Heather J.Scordo, MichaelChung, David J.Shah, GunjanLahoud, Oscar B.Thoren, KatieMurata, KazunoriRamanathan, LakshmiArcila, Maria E.Ho, CalebRoshal, MikhailDogan, AhmetGiralt, SergioKorde, Neha
- [28] Correlation of minimal residual disease negativity (MRD-) with prognosis in high-risk myeloma (HRM).JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)Kunacheewa, ChutimaPatel, Krina K.Lee, Hans ChulheeThomas, Sheeba K.Amini, BehrangSrour, SamerBashir, QaiserQazilbash, Muzaffar H.Weber, Donna M.Neelapu, Sattva SwarupOrlowski, Robert Z.Feng, LeiLin, PeiManasanch, Elisabet Esteve
- [29] EARLY DEATH IN MULTIPLE MYELOMA. ANALYSIS OF PATIENTS IN REAL-WORLD PRACTICEHAEMATOLOGICA, 2019, 104 : 14 - 15Lakhwani Lakhwani, S.Hernandez Garcia, M. T.Lorenzo Barreto, P.Cabrera Brito, D.Fernandez Gonzalez, M.Diaz Gomez, M.Raya Sanchez, J. M.
- [30] Minimal residual disease negativity in multiple myeloma is associated with intestinal microbiota compositionBLOOD ADVANCES, 2019, 3 (13) : 2040 - 2044Pianko, Matthew J.Devlin, Sean M.Littmann, Eric R.Chansakul, AisaraMastey, DonnaSalcedo, MeghanFontana, EmilyLine, LilanTavitian, ElizabetSlingerland, John B.Slingerland, Ann E.Clurman, AnnelieGomes, Antonio L. C.Taur, YingPamer, Eric G.Peled, Jonathan U.van den Brink, Marcel R. M.Landgren, OlaLesokhin, Alexander M.